Nonalcoholic fatty liver disease (NAFLD)—A new cardiovascular risk factor in peritoneal dialysis patients

Peritoneal Dialysis International

Volumn 36, Issue 4, 2016, Pages 427-432

  Mikolasevic, Ivana ^a   Milic, Sandra ^a   Racki, Sanjin ^a   Zaputovic, Luka ^a   Stimac, Davor ^a   Radic, Mladen ^a   Markic, Dean ^a   Orlic, Lidija ^a  

^a KBC RIJEKA   (Croatia)

Author keywords

Cardiovascular risk; Nonalcoholic fatty liver disease; Peritoneal dialysis

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; HEMOGLOBIN;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BODY MASS; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; ELASTOGRAPHY; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; HYPERTENSION; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PERITONEAL DIALYSIS; PREVALENCE; PRIORITY JOURNAL; VERY ELDERLY; CARDIOVASCULAR DISEASES; COMPLICATION; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; RISK FACTOR; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PERITONEAL DIALYSIS; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 84977569006     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2014.00223     Document Type: Article

References (26)

1. Wang AJM. Cardiovascular risk factors in peritoneal dialysis patients revisited. Perit Dial Int 2007; 27(S2):S223-7.
2. Garcia-Lopez E, Carrero JJ, Suliman ME, Lindholm B, Stenvinkel P. Risk factor for cardiovascular disease in patients undergoing peritoneal dialysis. Perit Dial Int 2007; 27(S2):S205-9.
3. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010; 363:1341-50.
4. Brea A, Mosquera D, Martin E, Arizti A, Cordero JL, Ros E. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vasc Biol 2005; 25:1045-50.
5. Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G, Zenari L, et al. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 2006; 29:132-30.
6. Villanova N, Moscatiello S, Ramilli S, Bugianesi E, Magalotti D, Vanni E, et al. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 2005; 42:473-80.
7. Assy N, Dijbre A, Farah R, Grosovski M, Marmor A. Presence of coronary plaques in patients with nonalcoholic fatty liver disease. Radiology 2010; 254:393-400.
8. Yilmaz Y, Alahdab YO, Yonal O, Kurt R, Kedrah AE, Celikel CA, et al. Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis. Metabolism 2010; 59:1327-30.
9. Manco M, Ciampalini P, DeVito R, Vania A, Cappa M, Nobili V. Albuminuria and insulin resistance in children with biopsy proven non-alcoholic fatty liver disease. Pediatr Nephrol 2009; 24:1211-7.
10. Targher G, Bertolini L, Rodella S, Lippi G, Zoppini G, Chonchol M. Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis. Clin J Am Soc Nephrol 2010; 5:2166-71.
11. Mikolasevic I, Racki S, Bubic I, Jelic I, Stimac D, Orlic L. Chronic kidney disease and nonalcoholic fatty liver disease proven by transient elastography. Kidney Blood Press Res 2013; 37:305-10.
12. Musso G, Gambino R, Tabibian JH, Ekstedt M, Kechagias S, Hamaguchi M, et al. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. PLoS Med 2014; 11(7):e1001680.
13. Targher G, Mantovani A, Pichiri I, Mingolla L, Cavalieri V, Mantovani W, et al. Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes. Diabetes Care 2014; 37:1729-36.
14. Singal AK, Salameh H, Kuo YF, Wiesner RH. Evolving frequency and outcomes of simultaneous liver kidney transplants based on liver disease etiology. Transplantation 2014; 98:216-21.
15. Mikolasevic I, Orlic L, Milic S, Zaputovic L, Lukenda V, Racki S. Nonalcoholic fatty liver disease (NAFLD) proven by transient elastography in hemodialysis patients; is it a new risk factor for adverse cardiovascular events? Blood Purif 2014; 37:259-65.
16. Lai YC, Cheng BC, Hwang JC, Lee YT, Chiu CH, Kuo LC, et al. Association of fatty liver disease with nonfatal cardiovascular events in patients undergoing maintenance hemodialysis. Nephron Clin Pract 2013; 124(3-4):218-23.
17. Neri S, Signorelli SS, Scuderi R, Bruno M, Bertino G, Clementi A, et al. Carotid intima-media thickness and liver histology in hemodialysis patients with nonalcoholic fatty liver disease. Int J Angiol 2011; 20:149-56.
18. Wu HY, Hung KY, Hu FC, Chen YM, Chu TS, Huang JW, et al. Risk factors for high dialysate glucose use in PD patients-a retrospective 5-year cohort study. Perit Dial Int 2010; 30:448-55.
19. Sasso M, Beaugrand M, de Ledinghen V, Douvin C, Marcellin P, Poupon R, et al. Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol 2010; 36(11):1825-35.
20. Han SS, Ahn JM, Chin HJ, Chae DW, Oh KH, Joo KW, et al. Impact of C-reactive protein and pulse pressure evaluated at the start of peritoneal dialysis on cardiovascular events in the course of treatment with peritoneal dialysis. Perit Dial Int 2010; 30:300-10.
21. Stel VS, Kramer A, Zoccali C, Jager KJ. The 2006 ERA-EDTA registry annual report: a précis. J Nephrol 2009; 22:1-12.
22. Van Biesen W, Verbeke F, Vanholder R. Cardiovascular disease in hemodialysis and peritoneal dialysis: arguments pro peritoneal dialysis. Nephrol Dial Transplant 2007; 22:53-8.
23. Lizardi-Cervera J, Zapata-Aguilar D. Nonalcoholic fatty liver disease and its association with cardiovascular disease. Ann Hepatol 2009; 8:S40-3.
24. Targher G. Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens. Diabet Med 2007; 24:1-6.
25. Ramos de Oliveira Liberato I, PessoadeAlmeidaLopes E, Gomes de Mattos Cavalcante MA, Costa Pinto T, Fernades Moura I, Loureiro Júnior L. Liver enzymes in patients with chronic kidney disease undergoing peritoneal dialysis and hemodialysis. Clinics 2012; 67(2)131-4.
26. Dowman JK, Tomlinson JW, Newsome N. Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2011; 33:525-40.